AU4790800A - Treatment of acute myocardial infarction with a substance related to the growth hormone axis - Google Patents

Treatment of acute myocardial infarction with a substance related to the growth hormone axis

Info

Publication number
AU4790800A
AU4790800A AU47908/00A AU4790800A AU4790800A AU 4790800 A AU4790800 A AU 4790800A AU 47908/00 A AU47908/00 A AU 47908/00A AU 4790800 A AU4790800 A AU 4790800A AU 4790800 A AU4790800 A AU 4790800A
Authority
AU
Australia
Prior art keywords
treatment
myocardial infarction
growth hormone
acute myocardial
substance related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47908/00A
Inventor
Bengt-Ake Bengtsson
Entela Bollano
Jorgen Isgaard
Elmir Omerovic
Finn Waagstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sahltech i Goteborg AB
Original Assignee
Sahltech i Goteborg AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech i Goteborg AB filed Critical Sahltech i Goteborg AB
Publication of AU4790800A publication Critical patent/AU4790800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU47908/00A 1999-05-05 2000-05-03 Treatment of acute myocardial infarction with a substance related to the growth hormone axis Abandoned AU4790800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9901634 1999-05-05
SE9901634A SE9901634D0 (en) 1999-05-05 1999-05-05 Treatment of myocardial infarction with a substance related to the growth hormone axis
PCT/SE2000/000844 WO2000067770A1 (en) 1999-05-05 2000-05-03 Treatment of acute myocardial infarction with a substance related to the growth hormone axis

Publications (1)

Publication Number Publication Date
AU4790800A true AU4790800A (en) 2000-11-21

Family

ID=20415485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47908/00A Abandoned AU4790800A (en) 1999-05-05 2000-05-03 Treatment of acute myocardial infarction with a substance related to the growth hormone axis

Country Status (4)

Country Link
EP (1) EP1173190A1 (en)
AU (1) AU4790800A (en)
SE (1) SE9901634D0 (en)
WO (1) WO2000067770A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1536817A1 (en) 2002-08-23 2005-06-08 Gestion Univalor Société en Commandite Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
EP1529533A1 (en) * 2003-11-06 2005-05-11 Sahltech I Göteborg AB Use of GH secretagogues in hypoxic-ischemic brain injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100099D0 (en) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab USE OF GROWTH FACTOR
US5610134A (en) * 1994-04-15 1997-03-11 Genentech, Inc. Treatment of congestive heart failure
AU737065B2 (en) * 1997-07-04 2001-08-09 Pharmacia Ab Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase B (PKB) activity

Also Published As

Publication number Publication date
EP1173190A1 (en) 2002-01-23
WO2000067770A1 (en) 2000-11-16
SE9901634D0 (en) 1999-05-05

Similar Documents

Publication Publication Date Title
AU2164101A (en) Fungicidal combinations of active substances
AUPQ402999A0 (en) Improvements in or relating to growth containers
AU5761700A (en) Cold-plasma treatment of seeds to remove surface materials
AU5628600A (en) Insulin-like growth factor agonist molecules
AU3064000A (en) Coated graphite crucible
AU7906998A (en) Compounds with growth hormone releasing properties
AU2382097A (en) Compounds with growth hormone releasing properties
AU6204899A (en) Novel imidazoles with anti-inflammatory activity
AU2506500A (en) Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism
AU4187200A (en) The use of domains of type iv collagen t inhibit angiogenesis an tumour growth
AU4790800A (en) Treatment of acute myocardial infarction with a substance related to the growth hormone axis
AU1702500A (en) Utilization of a magneto-resistive material
AU6294700A (en) Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines
AU6036100A (en) New pharmaceutically active compounds
AU5245700A (en) Coatings with the use of natural materials
AU8508398A (en) Treatment of diabetes with synthetic beta cells
AU7609298A (en) Treatment of heart failure with growth hormone
AU1970197A (en) Use of steroid compounds to prevent non-cancerous tissue growth
AU1652000A (en) Improvements related to medical containers
AU4777300A (en) Fixation material with the use of root spread
AU5223699A (en) Growth of bulk single crystals of aluminum
AU2288301A (en) Production of recombinant organisms
AU2682800A (en) Self watering growing unit
AU4532600A (en) Biologically active fertiliser composition
AU5859900A (en) Fishing reel of the multiplier type

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase